- Investopedia•11 hours ago
The Medicines and Healthcare Products Regulatory Agency (MHRA) sees greater benefits in making the drug prescription free, as men have been reluctant to consult a doctor and end up buying the drug from ...
- MarketWatch•12 hours ago
These dividend plays should hang tough even if the market does take a turn for the worse.
Glaxo is relieved after the FDA apparently did not approve Mylan's generic version of GSK's Advair.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||32.63 - 33.05|
|52 Week Range||31.90 - 58.16|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||467.29|
|Dividend & Yield||1.36 (4.13%)|
|1y Target Est||N/A|